HPMCAS - Hydroxypropyl methylcellulose acetate succinate

Abstract The coating process for solid dosage forms is widely used in the pharmaceutical industry but presents challenges for small-scale...

As a high number of active pharmaceutical ingredients (APIs) under development belong to BCS classes II and IV, the need...

The interplay between drug and polymer chemistry and its impact on drug release from an amorphous solid dispersion (ASD) is...

Abstract Amorphous solid dispersion (ASD) is an effective approach for enhancing the solubility, dissolution, and bioavailability of poorly water-soluble drugs....

Opioid misuse is a public health crisis in the United States. In response, the FDA has approved drug products with...

Abstract Three-dimensional printing (3DP) is an emerging technology, offering the possibility for the development of dose-customized, effective, and safe solid...

Producing amorphous solid dispersions (ASDs) by hot-melt extrusion (HME) is favorable from an economic and ecological perspective but also limited...

Implants are drug delivery platforms that consist of a drug-polymer matrix with the ability of providing a localized and efficient...

Filament formulation for FDM is a challenging and time-consuming process. Several pharmaceutical polymers are not feedable on their own. Due...

Abstract Amorphous solid dispersion (ASD) is a well-established strategy for enhancing the solubility and bioavailability of poorly soluble drugs. A...